Skip to content

Goal directed fluid therapy in aneurysmal subarachnoid haemorrhage

Goal directed fluid therapy during endovascular therapeutic procedures following aneurysmal subarachnoid haemorrhage: A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041813
Enrollment
20
Registered
2022-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Goal directed therapy: Goal directed therapy algorithm (During the total intra-operative period) Control Intervention1: Standard fluid therapy group: Clinical experience based on hemod

Sponsors

Department of Neuroanaesthesia Critical Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient aged > 18 years. 2) American Society of Anaesthesiologist (ASA) physical status 1 and 2. 3) World Federation of Neurologic Surgeons (WFNS) grade I to II aSAH and who were scheduled for an endovascular therapeutic procedure for aSAH under general anaesthesia within 5 days of aneurysm rupture.

Exclusion criteria

Exclusion criteria: 1) Patient refusal 2) Patient aged 3) Pregnant women 4) American Society of Anaesthesiologist (ASA) physical status 3 and above. 5) World Federation of Neurologic Surgeons (WFNS) grade III and above aSAH and who were scheduled for an endovascular therapeutic procedure for aSAH under general anaesthesia beyond 5 days of aneurysm rupture. 6) An unruptured aneurysm(s) or did not have aSAH. 7) A previous clipping or coiling procedure for the same aneurysm. 8) Undergone a concomitant extracranial-intracranial bypass procedure or other non-neurosurgical procedure. 9) Patient allergic to medications

Design outcomes

Primary

MeasureTime frame
Total duration of hypovolemia.Timepoint: At the end of procedure

Secondary

MeasureTime frame
1)Total duration of hypotension 2)Incidence of dehydration just before induction of anesthesia. 3)Volume of fluid infused. 4)Incidence of vasospasm. 5)Incidence of delayed cerebral ischemia (DCI). 6)Duration of ICU stay 7)Duration of hospital stay 8)Neurological outcome at discharge 9)Incidence of post-operative complications till discharge - cardiac, pulmonary and other systemic complications. Timepoint: Before induction, at the end of procedure, during hospital stay and at discharge

Countries

India

Contacts

Public ContactSaurav Singh

AIIMS New Delhi

hodneuroanaesthesia@gmail.com9871045824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026